Overview
Disorder of multiple glycosylation is a group of rare inherited metabolic conditions that affect a process called glycosylation. Glycosylation is the way your body attaches sugar molecules (called glycans) to proteins and fats. These sugar-coated molecules are essential for nearly every cell and organ in the body to work properly. When this process goes wrong in multiple ways at once, it can cause problems in many different organ systems, which is why these conditions are sometimes called congenital disorders of glycosylation (CDG) affecting multiple pathways. Because glycosylation is so important throughout the body, symptoms can be very wide-ranging. Common problems include developmental delay, intellectual disability, poor muscle tone (hypotonia), failure to thrive, liver problems, blood clotting issues, seizures, and skeletal abnormalities. Many affected children show signs from birth or early infancy. The severity varies greatly depending on the specific genetic cause, ranging from mild to life-threatening. There is currently no cure for most forms of this disorder. Treatment is mainly supportive and focuses on managing individual symptoms. For example, physical therapy can help with motor skills, anti-seizure medications may be used for epilepsy, and nutritional support can address feeding difficulties. In a small number of specific subtypes, targeted treatments such as mannose supplementation (for MPI-CDG) have shown benefit. Research into new therapies is ongoing, and early diagnosis through genetic testing is important to guide care and connect families with the right specialists.
Key symptoms:
Developmental delayIntellectual disabilityLow muscle tone (floppy baby)Failure to thrive or poor weight gainSeizures or epilepsyLiver problemsBlood clotting abnormalitiesAbnormal fat distributionInverted nipplesCrossed eyes (strabismus)Skeletal abnormalitiesHeart problemsImmune system weaknessFeeding difficultiesVision problems
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsJohns Hopkins University — PHASE2
Icahn School of Medicine at Mount Sinai
National Human Genome Research Institute (NHGRI)
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Disorder of multiple glycosylation.
2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Disorder of multiple glycosylation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of multiple glycosylation.
Community
No community posts yet. Be the first to share your experience with Disorder of multiple glycosylation.
Start the conversation →Latest news about Disorder of multiple glycosylation
No recent news articles for Disorder of multiple glycosylation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific subtype of congenital disorder of glycosylation does my child have, and what does that mean for their future?,Are there any targeted treatments available for our specific subtype?,What specialists should we see regularly, and how often?,What emergency situations should we watch for, and what should we do if they happen?,Are there any clinical trials or new research studies we could participate in?,What therapies (physical, occupational, speech) would benefit my child the most right now?,Should other family members be tested, and what are the chances of having another affected child?
Common questions about Disorder of multiple glycosylation
What is Disorder of multiple glycosylation?
Disorder of multiple glycosylation is a group of rare inherited metabolic conditions that affect a process called glycosylation. Glycosylation is the way your body attaches sugar molecules (called glycans) to proteins and fats. These sugar-coated molecules are essential for nearly every cell and organ in the body to work properly. When this process goes wrong in multiple ways at once, it can cause problems in many different organ systems, which is why these conditions are sometimes called congenital disorders of glycosylation (CDG) affecting multiple pathways. Because glycosylation is so impo
Are there clinical trials for Disorder of multiple glycosylation?
Yes — 2 recruiting clinical trials are currently listed for Disorder of multiple glycosylation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.